• Immunohistochemistry analysis of paraffin-embedded human brain tissue, using TSN Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of lysates from Jurkat cells, using TSN Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of various cells using Translin Polyclonal Antibody diluted at 1:2000. Secondary antibody was diluted at 1:20000

Anti-TSN antibody (101-150 aa) (STJ96087)

SKU:
STJ96087

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Translin (101-150 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:40000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: TSN
Gene ID: 7247
Uniprot ID: TSN_HUMAN
Immunogen Region: 101-150 aa
Specificity: Translin Polyclonal Antibody detects endogenous levels of Translin protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human TSN at the amino acid range 101-150
Protein Name Translin
Component 3 Of Promoter Of Risc
C3po
Database Links Reactome: R-HSA-426486
Cellular Localisation Cytoplasm
Nucleus
Alternative Antibody Names Anti-Translin antibody
Anti-Component 3 Of Promoter Of Risc antibody
Anti-C3po antibody
Anti-TSN antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance